Description

Gujarat Kidney and Super Speciality Limited added to BSE IPO index effective January 1, 2026, and Dachepalli Publishers Limited added to BSE SME IPO index effective December 31, 2025.

Summary

BSE has announced the addition of two newly listed companies to its indices. Gujarat Kidney and Super Speciality Limited (ticker: 544666) will be added to the BSE IPO index effective January 1, 2026, following its listing on December 30, 2025. Dachepalli Publishers Limited (ticker: 544667) will be added to the BSE SME IPO index effective December 31, 2025, following its listing on the SME platform on December 30, 2025.

Key Points

  • Gujarat Kidney and Super Speciality Limited (544666) listed on BSE effective December 30, 2025
  • Gujarat Kidney and Super Speciality Limited to be added to BSE IPO index at open on January 1, 2026
  • Dachepalli Publishers Limited (544667) listed on BSE SME platform effective December 30, 2025
  • Dachepalli Publishers Limited to be added to BSE SME IPO index at open on December 31, 2025
  • Changes included in end-of-day corporate action file (*.SDE)
  • Reference notices: 20251229-15 and 20251229-31

Regulatory Changes

No regulatory changes. This is a standard index maintenance action following new company listings.

Compliance Requirements

No specific compliance actions required. Market participants tracking these indices should note the additions for portfolio rebalancing and index tracking purposes.

Important Dates

  • December 30, 2025: Both companies commence trading on BSE
  • December 31, 2025: Dachepalli Publishers Limited added to BSE SME IPO index (at open)
  • January 1, 2026: Gujarat Kidney and Super Speciality Limited added to BSE IPO index (at open)

Impact Assessment

Minimal market impact. These are routine index additions for newly listed companies. Impact is limited to:

  • Index fund managers and passive investors tracking BSE IPO and BSE SME IPO indices will need to adjust holdings
  • Potential buying pressure from index-tracking funds on the effective dates
  • Increased visibility for the newly listed companies within the index ecosystem
  • No impact on broader market operations or trading rules

Impact Justification

Routine index additions for newly listed companies following standard listing procedures. Limited market-wide impact, primarily informational for index tracking and passive fund managers.